FC
Finepoint Capital Portfolio holdings
AUM
$504M
This Quarter Return
-12.45%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$201M
AUM Growth
+$201M
(-31%)
Cap. Flow
-$49.1M
Cap. Flow
% of AUM
-24.47%
Top 10 Holdings %
Top 10 Hldgs %
75.88%
Holding
39
New
2
Increased
12
Reduced
2
Closed
9
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$11.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
$2.41M |
| 3 |
Ascendis Pharma
ASND
|
$2.25M |
| 4 |
Amicus Therapeutics
FOLD
|
$1.99M |
| 5 |
Cytokinetics
CYTK
|
$1.84M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$22M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$16.8M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$14.4M |
| 4 |
Clarivate
CLVT
|
$11.9M |
| 5 |
Bausch Health
BHC
|
$9.32M |
Sector Composition
| 1 | Healthcare | 99.35% |
| 2 | Technology | 0% |